Main Content

Press Release

Elekta and MedCom GmbH to Develop Improved Patient Positioning for Cancer Care

Stock

2009-03-18

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, today announced collaboration with MedCom GmbH for the joint development of patient position verification management.


Elekta and MedCom have identified product collaboration projects within the Particle Therapy market which will enable the integration of MOSAIQ® Oncology Information Systems from Impac Software , an Elekta Group, with the VeriSuite System, MedCom's high precision patient position verification system. VeriSuite is a collection of software applications that are used in different scenarios to verify and control the position of a patient on a treatment table or a treatment chair.

“MedCom plans to work with Elekta to provide our customers with innovative approaches to high precision patient positioning,” says Prof. Dr Ing Georgios Sakas, Managing Director, MedCom GmbH. “The installation in the Inclined Beam treatment room in ProCure's Treatment and Development Center in Bloomington, Indiana and the new ProCure treatment center in Oklahoma City, Oklahoma will benefit from the joint development.”

"Elekta is looking forward to working closely with MedCom to optimize our customers clinical workflow in managing the challenges associated with patient positioning,” says Stewart Pegrum, Global Business Manager for Particle Therapy, Elekta. “The real-time motion data generated by the VeriSuite System introduces new and exciting options which will advance IMPT approaches, as well as provide consolidated data management solutions for our mutual Particle Therapy customers.”

###

About MedCom
MedCom has been originally founded in 1997 as a spin-off of the Fraunhofer Institute for Computer Graphics (IGD), the world expert R&D Institution for Computer Graphics Technologies. Since 2006 is MedCom an entirely privately owned company. MedCom offers innovative & advanced imaging-based products with emphasis on cancer treatment, interventional & surgical navigation and specialized telemedicine solutions (trauma, military & special forces, rural areas, satellite).  As an OEM company MedCom is providing products to a large number of world-wide acting providers of integrated clinical solutions, but also high-end clinics from the research sector. More information is available at www.medcom-online.de .

 

###

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
 Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.lee@elekta.com
 Time zone: EDT: Eastern Daylight Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com